344 filings
Page 2 of 18
8-K
fhkn28
10 Mar 23
Other Events
7:01am
8-K
muo255dpo
23 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:03pm
8-K
ctgg3ts bjh
1 Sep 22
Other Events
4:37pm
8-K
srq5kvd1 gzeo
23 May 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
lsj3ze8mth
12 May 22
Entry into a Material Definitive Agreement
8:31am
8-K
j61jf
22 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
8-K
cnqvsw33
11 Apr 22
Entry into a Material Definitive Agreement
8:03am
8-K
9h625t372r4tpjpat
10 Jan 22
Departure of Directors or Certain Officers
4:28pm
8-K
z0kt t19v1wuwn9
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
u23bxe17tmfp3 ere0
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
jsk cfq43fx
25 Oct 21
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research
2:03pm
8-K
7a7vh9wv3k z7
2 Sep 21
Seelos Therapeutics Announces Senior Management Appointments
4:01pm
8-K
h6ylt tcpa6amx6xjjm
17 Jun 21
Termination of a Material Definitive Agreement
4:14pm
8-K
oeikfh
24 May 21
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
4:15pm
8-K
qzuf8gxo1
21 May 21
Material Modifications to Rights of Security Holders
4:29pm
8-K
ydo3huptf2p
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
8-K
o5x8hxtd2 c9nrx4
17 May 21
Regulation FD Disclosure
6:12am
8-K
pf0abbu kgrh
18 Feb 21
Entry into a Material Definitive Agreement
7:05am
8-K
o9sgdl 294kvf
28 Jan 21
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares
10:14am
8-K
wnaqx 74sid8
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm